Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN OBSERVATIONAL SAFETY STUDY FOR PREVENAR 13 AMONG CHINESE CHILDREN

NCT03656939 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN OBSERVATIONAL SAFETY STUDY FOR PREVENAR 13 AMONG CHINESE CHILDREN
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 1, 2018
Completion date
July 31, 2020
Enrollment
21,240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apnea, fever, seizures, urticaria and angioedema